Here's Why Cardinal Health (CAH) is a Strong Value Stock

Cardinal Health (CAH) is highlighted as a strong value stock, meriting a Zacks Rank #2 (Buy) and top-tier 'A' scores for both Value and VGM. This assessment is supported by an attractive forward P/E of 15.76 and recent positive analyst revisions, with seven analysts raising fiscal 2026 earnings estimates by $0.20 to $9.41 per share. These factors, alongside an average earnings surprise of +9.2%, suggest CAH warrants attention from institutional investors for potential outperformance.

Analysis

Cardinal Health (CAH) is presented with strong quantitative signals suggesting it is an attractive value investment, according to the provided research. The company has been assigned a Zacks Rank #2 (Buy), supported by top-tier 'A' grades for its Value and composite VGM (Value, Growth, Momentum) scores. This value thesis is substantiated by a specific valuation metric, a forward P/E ratio of 15.76. Further bolstering the positive outlook are recent upward earnings revisions for fiscal 2026 from seven different analysts, which have collectively lifted the consensus earnings per share estimate by $0.20 to $9.41. This positive analyst sentiment is complemented by the company's historical performance, with CAH reporting an average positive earnings surprise of 9.2%, indicating a consistent ability to exceed market expectations. The combination of these factors—favorable valuation, positive earnings momentum, and a track record of outperformance—underpins the stock's strong rating.

Key Decisions for Investors

• Value-oriented investors should consider CAH as a potential addition to their portfolios, given its attractive forward P/E of 15.76 and strong 'A' rating for value.
• Investors should closely monitor future analyst earnings revisions for fiscal 2026, as the current positive momentum is a key pillar of the bullish thesis presented in this analysis.
• Given the company’s history of delivering an average earnings surprise of 9.2%, investors may want to position for potential upside ahead of subsequent earnings announcements, though past performance is not indicative of future results.